John L. Green - Jan 25, 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Financial Officer
Signature
/s/ Ryan Murr, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
Jan 25, 2022
Transactions value $
$1,112,220
Form type
4
Date filed
1/27/2022, 04:47 PM
Next filing
Feb 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $1.11M +225K $4.94 225K Jan 25, 2022 Common Stock 225K $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.